Harvard Bioscience (HBIO) Short Interest Ratio & Short Volume $2.11 +0.01 (+0.48%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Harvard Bioscience Short Interest DataHarvard Bioscience (HBIO) has a short interest of 450,100 shares. This marks a 20.32% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.1, indicating that it would take 3.1 days of the average trading volume of 123,591 shares to cover all short positions.Current Short Interest450,100 sharesPrevious Short Interest374,100 sharesChange Vs. Previous Month+20.32%Dollar Volume Sold Short$990,220.00Short Interest Ratio3.1 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares43,617,000 sharesPercentage of Shares Shorted1.03%Today's Trading Volume322,348 sharesAverage Trading Volume123,591 sharesToday's Volume Vs. Average261% Short Selling Harvard Bioscience? Sign up to receive the latest short interest report for Harvard Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHBIO Short Interest Over TimeHBIO Days to Cover Over TimeHBIO Percentage of Float Shorted Over Time Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. Harvard Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024450,100 shares $990,220.00 +20.3%N/A3.1 $2.20 11/15/2024374,100 shares $800,574.00 -6.2%N/A2.7 $2.14 10/31/2024398,900 shares $937,415.00 +13.8%N/A3.4 $2.35 10/15/2024350,600 shares $858,970.00 +11.4%N/A3.2 $2.45 9/30/2024314,700 shares $846,543.00 -26.7%N/A2.8 $2.69 9/15/2024429,100 shares $1.24 million +0.6%N/A3.3 $2.88 Get the Latest News and Ratings for HBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Harvard Bioscience and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024426,600 shares $1.23 million -0.1%1.1%2.9 $2.88 8/15/2024426,800 shares $1.22 million -4.4%1.1%2.8 $2.86 7/31/2024446,500 shares $1.43 million +3.7%1.1%3 $3.20 7/15/2024430,700 shares $1.43 million -19.4%1.1%2.8 $3.32 6/30/2024534,400 shares $1.52 million +38.4%1.3%3.6 $2.85 6/15/2024386,200 shares $1.12 million -16.3%1.0%3.1 $2.90 5/31/2024461,500 shares $1.46 million -25.6%N/A3.9 $3.17 5/15/2024620,100 shares $2.14 million -9.0%N/A6.5 $3.45 4/30/2024681,200 shares $2.60 million +1.2%N/A7.5 $3.82 4/15/2024673,000 shares $2.99 million +5.7%N/A7.7 $4.44 3/31/2024636,700 shares $2.70 million -11.2%N/A7.6 $4.24 3/15/2024716,600 shares $2.90 million +0.5%N/A8.5 $4.05 2/29/2024712,900 shares $3.09 million -3.4%1.8%8.4 $4.33 2/15/2024738,300 shares $3.59 million -6.5%1.9%8.5 $4.86 1/31/2024789,400 shares $3.47 million -8.8%2.0%9.1 $4.40 1/15/2024865,500 shares $4.24 million -4.8%2.2%9.9 $4.90 12/31/2023909,500 shares $4.87 million +3.1%2.3%10.6 $5.35 12/15/2023881,900 shares $4.32 million -7.6%2.2%10.1 $4.90 11/30/2023954,600 shares $4.07 million -10.8%2.4%10.7 $4.26 11/15/20231,070,000 shares $4.55 million +5.9%2.7%11.8 $4.25 10/31/20231,010,000 shares $4.43 million -2.9%2.6%9.6 $4.39 10/15/20231,040,000 shares $4.31 million -1.0%2.6%8.4 $4.14 9/30/20231,050,000 shares $4.52 million +13.0%2.7%7.7 $4.30 9/15/2023928,900 shares $4.23 million -3.7%2.3%5.8 $4.55 8/31/2023964,800 shares $4.25 million -1.9%2.4%3.7 $4.41 8/15/2023983,800 shares $4.17 million +0.6%2.5%3.5 $4.24 7/31/2023978,300 shares $4.55 million -4.1%2.5%3.3 $4.65 7/15/20231,020,000 shares $5.57 million -1.9%2.6%3.3 $5.46 6/30/20231,040,000 shares $5.71 million +221.3%2.7%3.2 $5.49 6/15/2023323,700 shares $1.76 million -16.5%0.8%1 $5.44 5/31/2023387,500 shares $2.17 million +0.2%1.0%1.8 $5.59 5/15/2023386,700 shares $2.06 million +10.9%1.0%2.2 $5.34 4/30/2023348,800 shares $2.00 million +28.1%1.0%2.3 $5.72 4/15/2023272,200 shares $1.34 million -7.6%0.8%2.5 $4.93Did You See Trump’s Bombshell Exec. Order 001? (Ad)Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. 3/31/2023294,700 shares $1.24 million +14.9%0.8%3.1 $4.20 3/15/2023256,400 shares $676,896.00 -1.8%0.7%2.4 $2.64 2/28/2023261,100 shares $738,913.00 -1.3%0.7%2.3 $2.83 2/15/2023264,500 shares $812,015.00 +1.7%0.7%2.3 $3.07 1/31/2023260,000 shares $774,800.00 -2.1%0.7%1.9 $2.98 1/15/2023265,600 shares $778,208.00 -32.6%0.7%1.9 $2.93 12/30/2022394,100 shares $1.09 million +22.9%1.1%2.8 $2.77 12/15/2022320,600 shares $769,440.00 +9.4%0.9%2.1 $2.40 11/30/2022293,200 shares $750,592.00 +5.6%0.8%2.6 $2.56 11/15/2022277,700 shares $666,480.00 +8.1%0.8%2.6 $2.40 10/31/2022256,800 shares $690,792.00 -6.3%0.7%2.4 $2.69 10/15/2022274,100 shares $619,466.00 +2.5%0.8%2.3 $2.26 9/30/2022267,400 shares $684,544.00 +3.6%0.7%2.1 $2.56 9/15/2022258,200 shares $800,420.00 -5.6%0.7%1.3 $3.10 8/31/2022273,500 shares $902,550.00 -5.8%0.8%1.2 $3.30 8/15/2022290,300 shares $937,669.00 -8.0%0.8%1.1 $3.23 7/31/2022315,400 shares $1.19 million -13.8%0.9%1.1 $3.76 7/15/2022365,700 shares $1.33 million -21.2%1.0%1.2 $3.65 6/30/2022464,000 shares $1.67 million -72.1%1.4%1.5 $3.60 6/15/20221,660,000 shares $6.09 million +5.7%5.1%5.3 $3.67 5/31/20221,570,000 shares $5.75 million -1.3%4.3%7.1 $3.66 5/15/20221,590,000 shares $6.01 million +30.3%4.4%8.1 $3.78 4/30/20221,220,000 shares $6.37 million +11.9%3.3%6.7 $5.22 4/15/20221,090,000 shares $6.41 million +1.9%3.0%7.1 $5.88 3/31/20221,070,000 shares $6.64 million +7.0%2.9%7 $6.21 3/15/2022999,600 shares $5.89 million +24.6%2.7%6.6 $5.89 2/28/2022802,600 shares $4.33 million +2.7%2.2%5 $5.40 2/15/2022781,500 shares $4.29 million +20.1%2.1%4.9 $5.49 1/31/2022650,700 shares $3.79 million +9.4%1.8%4.2 $5.82 1/15/2022594,700 shares $3.60 million -2.1%N/A0 $6.06 12/31/2021607,700 shares $4.28 million +19.5%1.7%3.8 $7.05 12/15/2021508,500 shares $3.53 million -0.3%1.4%3 $6.94 11/30/2021509,900 shares $3.41 million +0.5%1.4%3.2 $6.69 11/15/2021507,200 shares $3.94 million -16.4%1.4%3.1 $7.77 10/29/2021606,400 shares $4.57 million +5.6%1.7%3.4 $7.53 10/15/2021574,000 shares $3.93 million -10.9%1.6%3.2 $6.84 9/30/2021644,000 shares $4.50 million -5.1%1.8%3.5 $6.98 9/15/2021678,300 shares $5.32 million +0.6%1.9%3.2 $7.84 8/31/2021674,400 shares $5.57 million +1.7%1.9%3.1 $8.26 8/13/2021663,300 shares $5.61 million +2.7%1.8%2.9 $8.46 7/30/2021646,200 shares $5.10 million -9.6%1.8%2.7 $7.89 7/15/2021715,100 shares $5.44 million +7.4%2.0%2.8 $7.61 6/30/2021665,800 shares $5.55 million -3.2%1.9%2.5 $8.33 6/15/2021688,000 shares $5.19 million -16.9%1.9%2.8 $7.55 5/28/2021828,000 shares $5.80 million -4.1%2.3%2.8 $7.00 5/14/2021863,600 shares $5.98 million +8.2%2.4%3.1 $6.92 4/30/2021798,200 shares $5.75 million -16.3%2.2%3.1 $7.20 4/15/2021953,700 shares $6.33 million +16.8%2.7%4.2 $6.64 3/31/2021816,500 shares $4.44 million +21.9%2.3%3.7 $5.44 3/15/2021669,800 shares $4.30 million +0.7%1.9%3.4 $6.42Did You See Trump’s Bombshell Exec. Order 001? (Ad)Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. 2/26/2021665,100 shares $2.88 million +4.6%2.0%5.2 $4.33 2/12/2021636,100 shares $2.98 million -1.8%1.8%5.3 $4.69 1/29/2021647,900 shares $2.93 million +5.5%1.9%5 $4.52 1/15/2021614,300 shares $2.55 million -0.1%1.8%4.7 $4.15 12/31/2020615,000 shares $2.63 million +5.2%1.8%5.2 $4.27 12/15/2020584,400 shares $2.48 million -7.7%1.7%4.9 $4.24 11/30/2020632,900 shares $2.45 million -11.1%1.8%5.3 $3.87 11/15/2020711,600 shares $2.88 million -44.8%2.1%5.9 $4.05 10/30/20201,290,000 shares $4.26 million -5.2%3.8%11.9 $3.30 10/15/20201,360,000 shares $4.43 million No Change4.0%11.8 $3.26 9/30/20201,360,000 shares $4.09 million -3.6%4.0%0 $3.01 9/15/20201,410,000 shares $4.53 million -0.7%4.1%5.4 $3.21 8/31/20201,420,000 shares $4.76 million -4.1%4.1%4.7 $3.35 8/14/20201,480,000 shares $5.42 million No Change4.3%4.7 $3.66 7/31/20201,480,000 shares $4.60 million +2.1%4.4%4.5 $3.11 7/15/20201,450,000 shares $4.89 million -40.8%4.3%4.2 $3.37 6/30/20202,450,000 shares $7.60 million +64.4%7.2%6.9 $3.10 6/15/20201,490,000 shares $4.05 million +41.9%4.4%6.4 $2.72 5/29/20201,050,000 shares $2.77 million +5.0%3.1%5.1 $2.64 5/15/20201,000,000 shares $2.58 million -9.1%2.9%4.6 $2.58 4/30/20201,100,000 shares $3.03 million +79.1%3.2%5.5 $2.75 4/15/2020614,300 shares $1.65 million -7.2%1.8%3.5 $2.68 3/31/2020662,100 shares $1.77 million -1.5%1.9%4.7 $2.68 3/13/2020672,400 shares $1.67 million +1.9%2.0%3.6 $2.48 2/28/2020659,700 shares $1.13 million +4.4%1.9%6.6 $1.71 2/14/2020632,100 shares $1.68 million -1.0%1.9%8 $2.65 1/31/2020638,200 shares $1.89 million +2.1%1.9%7.4 $2.96 1/15/2020625,200 shares $1.73 million -4.6%1.8%7.2 $2.76 12/31/2019655,100 shares $1.97 million -1.1%1.9%7.9 $3.00 HBIO Short Interest - Frequently Asked Questions What is Harvard Bioscience's current short interest? Short interest is the volume of Harvard Bioscience shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 450,100 shares of HBIO short. Learn More on Harvard Bioscience's current short interest. What is a good short interest ratio for Harvard Bioscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HBIO shares currently have a short interest ratio of 3.0. Learn More on Harvard Bioscience's short interest ratio. Is Harvard Bioscience's short interest increasing or decreasing? Harvard Bioscience saw a increase in short interest during the month of November. As of November 30th, there was short interest totaling 450,100 shares, an increase of 20.3% from the previous total of 374,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Harvard Bioscience's short interest compare to its competitors? Here is how the short interest of companies compare to Harvard Bioscience: Thermo Fisher Scientific Inc. (0.93%), Agilent Technologies, Inc. (1.00%), Mettler-Toledo International Inc. (1.56%), Illumina, Inc. (4.55%), Waters Co. (3.57%), Bio-Techne Co. (2.57%), Charles River Laboratories International, Inc. (4.26%), Bio-Rad Laboratories, Inc. (2.55%), Bruker Co. (3.21%), Pacific Biosciences of California, Inc. (19.86%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Harvard Bioscience stock? Short selling HBIO is an investing strategy that aims to generate trading profit from Harvard Bioscience as its price is falling. HBIO shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Harvard Bioscience? A short squeeze for Harvard Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HBIO, which in turn drives the price of the stock up even further. How often is Harvard Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HBIO, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Thermo Fisher Scientific Short Interest Data Agilent Technologies Short Interest Data Mettler-Toledo International Short Interest Data Illumina Short Interest Data Waters Short Interest Data Bio-Techne Short Interest Data Charles River Laboratories International Short Interest Data Bio-Rad Laboratories Short Interest Data Bruker Short Interest Data Pacific Biosciences of California Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HBIO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harvard Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harvard Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HBIO Stock Alerts